Sunday, February 17, 2013

Stem cell treatment for AMD

This is what a patient with age-related macular degeneration (ARMD) sees.

News on 2/17/2013:

TOKYO — Researchers in Japan have moved one step closer to clinical trials using adult stem cells in a therapy they hope will prove a cure for common sight problems.

The ethics committee at the Institute for Biomedical Research and Innovation in Kobe, last Wednesday approved a trial treatment for age-related macular degeneration (AMD) using induced Pluripotent Stem (iPS) cells.

The trial is aimed at creating retinal cells that can be transplanted into the eyes of patients suffering from AMD, a presently incurable disease that affects mostly middle-aged and older people and can lead to blindness.

Stem cell treatment vs artificial retina implant: the race is now on.

2 comments:

stemcelltherapy said...

There are so many cases where the regular mode of treatment seems to be insufficient so at that case research is always open for the right alternate, and in this regard it is the stem cell therapy that is doing amazingly well. Thank you very much.

Stem Cell Therapy

stem cells treatment said...

Stem cell therapy is an intervention strategy that introduces new adult stem cells into damaged tissue in order to treat disease or injury.